Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lissy de Ridder

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Journal of Crohn'S & Colitis|November 27, 2023
Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn's Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort StudyRenz C W Klomberg, Hella C van der Wal, Martine A Aardoom, et al.
Journal of Crohn'S & Colitis|March 19, 2023
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both TreatmentsMaria M E Jongsma, Lea M M Costes, Irma Tindemans, et al.
Inflammatory Bowel Diseases|January 3, 2024
Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn's Disease Exhibit Similar PharmacokineticsRuben J Colman, Stephanie A Vuijk, Ron A A Mathôt, et al.
Journal of Crohn'S & Colitis|February 7, 2015
Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort studySjoukje-Marije Haisma, Thijs Lijftogt, Angelika Kindermann, et al.
Journal of Crohn'S & Colitis|August 4, 2021
ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel DiseaseRoger Feakins, Joana Torres, Paula Borralho-Nunes, et al.
Journal of Crohn'S & Colitis|November 2, 2024
Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success ScoreMartha A C van Gaalen, Merel van Pieterson, Petra Waaijenberg, et al.
Inflammatory Bowel Diseases|January 26, 2012
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's diseaseRon Shaoul, Marlgozata Sladek, Dan Turner, et al.
Plos One|July 23, 2013
Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patientsMarieke A van Leeuwen, M Fleur du Pré, Roy L van Wanrooij, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 10, 2004
Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The NetherlandsLissy de Ridder, Johanna C Escher, Jan Bouquet, et al.
European Journal of Pediatrics|July 22, 2019
Quality of life and colorectal function in Crohn's disease patients that underwent ileocecal resection during childhoodKay Diederen, Lissy de Ridder, Patrick van Rheenen, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Journal of Crohn'S & Colitis|November 27, 2023
Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn's Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort StudyRenz C W Klomberg, Hella C van der Wal, Martine A Aardoom, et al.
Journal of Crohn'S & Colitis|March 19, 2023
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both TreatmentsMaria M E Jongsma, Lea M M Costes, Irma Tindemans, et al.
Inflammatory Bowel Diseases|January 3, 2024
Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn's Disease Exhibit Similar PharmacokineticsRuben J Colman, Stephanie A Vuijk, Ron A A Mathôt, et al.
Journal of Crohn'S & Colitis|February 7, 2015
Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort studySjoukje-Marije Haisma, Thijs Lijftogt, Angelika Kindermann, et al.
Journal of Crohn'S & Colitis|August 4, 2021
ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel DiseaseRoger Feakins, Joana Torres, Paula Borralho-Nunes, et al.
Journal of Crohn'S & Colitis|November 2, 2024
Effectiveness of Transitional Care in Inflammatory Bowel Disease; Development, Validation, and Initial Outcomes of a Transition Success ScoreMartha A C van Gaalen, Merel van Pieterson, Petra Waaijenberg, et al.
Inflammatory Bowel Diseases|January 26, 2012
Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's diseaseRon Shaoul, Marlgozata Sladek, Dan Turner, et al.
Plos One|July 23, 2013
Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patientsMarieke A van Leeuwen, M Fleur du Pré, Roy L van Wanrooij, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 10, 2004
Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The NetherlandsLissy de Ridder, Johanna C Escher, Jan Bouquet, et al.
European Journal of Pediatrics|July 22, 2019
Quality of life and colorectal function in Crohn's disease patients that underwent ileocecal resection during childhoodKay Diederen, Lissy de Ridder, Patrick van Rheenen, et al.
Pageof 13